Anadolu Medical Center
Anadolu Medical Center
Түркия, Істанбұл
Seref Komurcu
33 жылдар тәжірибе
аккредитациялар :
Аккредитация :
| Түркия | Австрия | Испания | |
| Тік ішек қатерлі ісігінде сәулелік терапия | бастап $7,000 | бастап $12,000 | бастап $10,000 |
| Сүт безі рагында химиотерапия | бастап $1,200 | бастап $15,000 | бастап $3,500 |
| Асқазанның резекциясы | бастап $16,470 | бастап $22,000 | бастап $9,000 |
| Асқазан рагына операция | бастап $22,320 | бастап $30,000 | бастап $25,000 |
Дәрігер - саркома, лимфома, ұйқы безі, өкпе және сүт безі қатерлі ісіктері бойынша маманданған тәжірибелі түрік медициналық онкологы. 20 жылдан астам тәжірибесі бар дәрігер ісік биологиясы, ісік иммунологиясы, қатерлі ісік иммунотерапиясы және нысаналы терапияларға назар аударады. 2019 жылдан бері дәрігер Анадолу Медициналық Орталығында медициналық онколог ретінде қызмет атқарып келеді және бұрын Стамбул Окан Университеті Медицина факультетінде және ГАТА Хайдарпаша Оқу Ауруханасында жетекшілік қызметтер атқарған. Дәрігер қатерлі ісік зерттеулері бойынша 40-тан астам жарияланымдардың авторы және Түрік Медициналық Онкология Қауымдастығының және Еуропалық Бас және Мойын Қоғамының мүшесі.<\/p>
Доктор Танрикулу — Анадолу медициналық орталығының ісік аурулары маманы (онколог). Оның медициналық дәреже алғаннан кейінгі жұмыс өтілі 17 жылды құрайды.
Доктор Мұстафа Солак асқазан-ішек жолдарының қатерлі ісіктерін емдеуге маманданған. Ол Хаджеттепе университетінің Онкология институтында тағылымдамадан өтті.
Dr. Vafi Atalay is an experienced oncological and general surgeon with 17 years in the field. He specializes in pancreatic, colon, rectal, and liver surgeries. He also performs advanced endoscopic procedures. Dr. Atalay has published 31 articles in national and international journals, making valuable contributions to medical literature.
He received the first prize at the 20th Congress Research Paper Competition. He also won the Best Research Award at the 5th Surgeon Research Congress. Dr. Atalay is a member of TSS, the Palestinian Medical Association, and IOA. His active involvement in these organizations shows his dedication to professional growth and surgical excellence.
Standard treatment for Stage 2 stomach cancer in Turkey follows a multimodal curative approach. Surgeons perform radical subtotal or total gastrectomy with D2 lymph node dissection. This is typically combined with perioperative chemotherapy. Multidisciplinary tumor boards at JCI-accredited centers coordinate these complex surgical and oncological protocols.
Bookimed Expert Insight: Clinical data shows a significant price difference between specialized oncology centers. While Memorial hospitals charge approximately $24,800 for radical total gastrectomy, Hisar Hospital Intercontinental offers a similar surgical procedure for around $10,500. Patients should prioritize clinics with D2 dissection experience, as this specific surgical technique is the primary driver of successful long-term outcomes for Stage 2 cases.
Patient Consensus: Patients emphasize that recovery after stomach removal is physically demanding. Many note that confirming a curative goal and surgical resectability through a multidisciplinary tumor board provided the most confidence before treatment.
Anadolu Medical Center, Medipol Mega, and the Memorial Health Group specialize in multidisciplinary stomach cancer care in Turkey. These JCI-accredited institutions utilize unified tumor boards. They integrate surgical oncology, medical oncology, and radiation therapy to treat stage 2 gastric cancer with American-standard protocols.
Bookimed Expert Insight: While many choose clinics based on individual surgeon fame, data shows university-affiliated centers offer superior coordination. For example, Anadolu Medical Center reports 65,000 annual patients and maintains unique oncology certifications from OECI. This institutional depth ensures that staging, pathology, and nutrition support are handled by dedicated specialists rather than generalists.
Patient Consensus: Patients emphasize that successful recovery depends on an integrated team and advise asking for a written multidisciplinary treatment plan. They note that having a single coordinator for imaging and surgery helps avoid delays in care.
Turkish JCI-accredited hospitals provide laparoscopic and robotic-assisted gastrectomy for stage 2 stomach cancer. Specialized centers utilize the da Vinci Xi system for precise tumor removal. These minimally invasive techniques involve small incisions. This leads to faster recovery and less pain compared to open surgery.
Bookimed Expert Insight: Surgeon volume is the most reliable quality indicator for robotic gastrectomy in Turkey. While many clinics advertise robotic technology, look for specialists like Prof. Dr. Kivanc Derya Peker who have performed 400+ specific gastric cancer surgeries. High-volume surgeons maintain better outcomes during complex D2 lymph node dissections than those primarily focused on bariatric weight-loss procedures.
Patient Consensus: Patients note that recovery is much easier with minimally invasive surgery. They recommend seeking second opinions to confirm if a tumor's location allows for a robotic approach.
Turkish hospitals routinely use contrast-enhanced computed tomography of the abdomen and thorax to stage Stage 2 gastric cancer. Most protocols include endoscopic ultrasound to determine tumor depth and lymph node involvement. Standard biopsies and PET-CT scans are typically performed to rule out distant metastasis before surgery.
Bookimed Expert Insight: Memorial Göztepe Hospital utilizes a high-resolution 512-slice CT and AI-supported 3 Tesla MRI for staging. These technologies provide significantly higher detail than older 64-slice scanners found in smaller clinics. This extra precision helps surgeons at Memorial and Anadolu Medical Center decide between immediate surgery or starting with neoadjuvant chemotherapy.
Patient Consensus: Patients note that doctors prioritize ruling out distant disease before surgery to ensure a successful outcome. Many suggest bringing original endoscopy images and biopsy reports to help the surgical team confirm the staging scans.
Adjuvant chemotherapy is not mandatory for all Stage 2 stomach cancer cases but remains the standard of care. Turkish oncologists use it to reduce high recurrence risks, especially after D2 lymph node dissection. Decisions depend on tumor biology, surgical margins, and the patient's overall fitness.
Bookimed Expert Insight: While many think only Istanbul offers top care, our data shows high-volume centers like Hisar Hospital Intercontinental perform 600+ complex gastric surgeries. These specialized surgeons often collaborate with Medical Oncologists like Professor Yesim Yildirim, who has 20+ years of experience. This multidisciplinary approach is vital because Stage 2 treatment strategies must balance aggressive drug protocols with the patient's ability to recover from major stomach resection.
Patient Consensus: Patients note that chemo is often recommended based on the final pathology report rather than being an automatic rule for every case. Many emphasize asking for a tumor board review if pathology shows clear margins but high-risk features.
Turkish oncology centers report a 5-year survival rate of 42% to 51.1% for Stage 2 gastric cancer. Specialized hospitals prioritize D2 lymph node dissection to improve these outcomes. Multi-specialty teams often combine surgery with perioperative chemotherapy to maximize success in treating this stage.
Bookimed Expert Insight: Success in Turkey is driven by surgeon volume rather than clinic size. Dr. Kivanc Derya Peker at Hisar Hospital has performed 600+ gastric surgeries. High-volume specialists often offer lower-cost packages, like $10,500, compared to $24,800 at other JCI-accredited centers for similar D2 dissection procedures.
Patient Consensus: Patients emphasize that recovery requires significant dietary adjustments and smaller, frequent meals. Many note that having an English-speaking coordinator helps manage the intense follow-up schedule and nutritional support needed after surgery.